TIM-3 expression in breast cancer

TIM-3 expression in breast cancer

Tumor-infiltrating lymphocytes (TILs) are predominantly present in breast cancer patients with estrogen receptor negative tumors, among whom increasing levels correlate with favorable outcomes. Nevertheless, currently available immune checkpoint inhibitors appear to benefit only a small number of wo...

Full description

Bibliographic Details
Main Authors: Samantha Burugu, Dongxia Gao, Samuel Leung, Stephen K. Chia, Torsten O. Nielsen
Format: Article
Language:English
Published: Taylor & Francis Group 2018-11-01
Series:OncoImmunology
Subjects:
tim-3
breast cancer
immunohistochemistry
tumor-infiltrating lymphocytes
lag-3
pd-1
pd-l1
immune checkpoints
Online Access:http://dx.doi.org/10.1080/2162402X.2018.1502128

Internet

http://dx.doi.org/10.1080/2162402X.2018.1502128

Similar Items